SCR-LIP-000421 · Claim · machine-readable JSON →

In premenopausal women with lipedema, serum endostatin (an angiogenesis inhibitor) was significantly reduced compared to controls (p=0.038), while adiponectin, chemerin, LBP, PCSK9, sCD163, sCD137, and IGFBP2 did not differ, suggesting altered vascular homeostasis without directly assessing varicose veins.

Claim at a glance

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-08-02

Evidence over time

Reduced Serum Endostatin in Premenopausal Women with Lipedema Suggests Altered Vascular Homeostasis. — Kempa S, Weiss TS, Tews HC, Prantl L, Müller M, Buechler C. (2026) ✓ verified — contextual · cross sectional · 2026 · reading confidence: high
“Reduced serum endostatin levels support a potential role for vascular dysfunction in the pathophysiology of lipedema.”
The study examines vascular dysfunction biomarkers in lipedema, addressing vascular pathophysiology broadly, but does not directly test the relationship between lipedema and varicose veins or clinical venous disease; it provides background

Population23 premenopausal women with lipedema and 23 age-matched healthy controls

Conditionlipedema

Exposurelipedema status

Comparatorhealthy premenopausal controls

Outcomeserum angiogenesis/vascular biomarkers (endostatin, IGFBP2, etc.)

Scopeauto-ingested from Layer 1 surveillance

Auto-ingested single source; not yet human-reviewed.